Ann Oncol

1. KALINSKY K, Barlow WE, Pathak HB, Puri RV, et al
   Corrigendum to "Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)": [Annals of Oncology 37 (2026) 1220-1229].
   Ann Oncol. 2026 Oct 20:S0923-7534(26)06772-4. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   
2. SLAMON DJ, Hortobagyi GN, Stroyakovskiy D, Yardley DA, et al
   Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2- early breast cancer: Six-year follow-up of the NATALEE trial.
   Ann Oncol. 2026 Oct 23:S0923-7534(26)08640-0. doi: 10.1016/j.annonc.2026.10.1288
   

   >> Share

   
   

   
   Ann Surg Oncol

3. GASS JS, Pesek S, Czerniecki B, Ryan J, et al
   An International Randomized Prospective Trial Comparing a Supine MRI-based Guidance System, The Breast Cancer Locator(TM), to Wire Localization for Breast-Conserving Surgery for Non-palpable Breast Cancer.
   Ann Surg Oncol. 2026 Oct 22. doi: 10.1245/s10434-026-20657.
   

   >> Share

   
   
4. FRASER K, Wilbers A, Reyes J, Helmer SD, et al
   Choosing Wisely in Rural America: Surgical Management of the Axilla in Elderly Patients with Clinically Node-negative, Hormone Receptor-positive Invasive Breast Cancer.
   Ann Surg Oncol. 2026 Oct 21. doi: 10.1245/s10434-026-20778.
   

   >> Share

   
   
5. YANG D, Abdul-Ghani S, Miyagi M, Yamauchi H, et al
   Factors Associated with Delays in Breast Cancer Surgery Among Patients From Neighboring Hawaiian Islands Treated on O'ahu.
   Ann Surg Oncol. 2026 Oct 20. doi: 10.1245/s10434-026-20770.
   

   >> Share

   
   
6. ARIMA J, Chida K, Wu R, Shima T, et al
   Androgen Receptor (AR) Expression is Associated with an Immune-Cold Phenotype and Reduced Response to Immune Checkpoint Inhibitors in ER-Positive/HER2-Negative Breast Cancer.
   Ann Surg Oncol. 2026 Oct 20. doi: 10.1245/s10434-026-20685.
   

   >> Share

   
   
7. SULLIVAN S, Mott S, Nataliansyah MM, Mobley EM, et al
   Recent National Trends in Time to Breast Cancer Surgery Before and After the COVID-19 Pandemic Onset and Predictors of Failure to Receive Timely Surgery.
   Ann Surg Oncol. 2026 Oct 19. doi: 10.1245/s10434-026-20719.
   

   >> Share

   
   
8. VARNEY CR, Pillai T, Oleck NC, Jiang Y, et al
   Decreasing Time to Definitive Breast Reconstruction: National Trends and Patient-Level Predictors.
   Ann Surg Oncol. 2026;33:10564-10573.
   

   >> Share

   
   
9. SHEN Y, Valentine L, Gao R, Brown S, et al
   Intraoperative Prediction of Mastectomy Skin Flap Necrosis using Standardized ICG Grading and Quantitative Perfusion Mapping.
   Ann Surg Oncol. 2026;33:10522-10533.
   

   >> Share

   
   
10. AFSAR AP, Mullen B, Moreira AA, Tran BV, et al
    Global Disparities in Insurance Coverage of Post-Mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2026;33:10760-10766.
    

    >> Share

    
    
11. MORANDO L, Millochau JC, Nos C, Couturaud B, et al
    Chest Wall Perforator Flaps in Oncoplastic Breast Surgery: A Series of 157 Consecutive Cases at the Paris Breast Center.
    Ann Surg Oncol. 2026;33:10805-10815.
    

    >> Share

    
    
12. ROHRICH RN, Soltani H, Snee I, Fan KL, et al
    A Decade Later: An Updated Systematic Review and Meta-analysis of Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence Following Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2026;33:10504-10521.
    

    >> Share

    
    

    
    BMC Cancer

13. CHANG X, Zuo S, Wang Z, Wang Z, et al
    Sleep patterns and breast cancer risk: a prospective cohort study integrating multi-omics and machine learning.
    BMC Cancer. 2026;26:1282.
    

    >> Share

    
    
14. MUZI CD, Veggi AB, Coutinho RPM, Albuquerque DBS, et al
    Regional divergence in female cancer mortality in Brazil signals the unequal pace of the cancer transition.
    BMC Cancer. 2026;26:1279.
    

    >> Share

    
    
15. ALMEIDA NR, Brenelli FP, de Paula Leite Kraft MB, de Azevedo NS, et al
    Survival implications of non-organized breast cancer screening in a Brazilian tertiary women's health center: a retrospective cohort study of 1517 patients.
    BMC Cancer. 2026;26:1284.
    

    >> Share

    
    
16. ZHAO S, He S, Zhou Y, Fan Y, et al
    Clinicopathologic features and prognostic factors of breast cancer brain metastases patients based on molecular subtypes: a real-world retrospective analysis.
    BMC Cancer. 2026;26:1275.
    

    >> Share

    
    
17. SALZER AT, Williams C, Skoluda S, Stylianou M, et al
    Neutrophils alter the metabolic profile of a coculture model of triple-negative breast cancer and stromal cells.
    BMC Cancer. 2026;26:1272.
    

    >> Share

    
    
18. TIAN L, Feng X, Liu M, Jiang J, et al
    Construction and validation of a predictive model for fear of progression among postoperative patients with breast cancer: a multi-center cross-sectional study.
    BMC Cancer. 2026;26:1267.
    

    >> Share

    
    

    
    Br J Cancer

19. PICHARDO MS, Hunt RP, Peterson LL, Pan K, et al
    Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women's Health Initiative randomized trial.
    Br J Cancer. 2026;135:1424-1429.
    

    >> Share

    
    

    
    Breast Cancer

20. ISHIGURO H, Hoshi N, Noda SE, Tokuda E, et al
    A phase II study combining radiotherapy and atezolizumab/nab-paclitaxel for inoperable or recurrent programmed death-ligand 1-positive triple-negative breast cancer: IMRad-Br study protocol and safety run-in.
    Breast Cancer. 2026 Oct 21. doi: 10.1007/s12282-026-01925.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

21. WANG Z, Wang Y, Cao Z, Jiang Y, et al
    Potential Molecular Links Between Benzophenone-3 and Breast Cancer: Network Toxicology, Machine Learning, Molecular Modeling, and Gene Expression Validation.
    Breast Cancer (Dove Med Press). 2026;18:632531.
    

    >> Share

    
    

    
    Breast Cancer Res

22. KAWAMURA C, Shimada K, Bhaskaran K, Konishi T, et al
    Herpes zoster risk among female survivors of breast cancer in Japan.
    Breast Cancer Res. 2026;28:179.
    

    >> Share

    
    
23. SHARKEY AR, Chen HY, Funso-Fayomi C, Pinder SE, et al
    Do new guidelines enable a more accurate comparison of [(18)F]FDG PET/CT features with histopathology in primary breast cancer?
    Breast Cancer Res. 2026;28:180.
    

    >> Share

    
    
24. ZHAO X, Bai JW, Dong LA, Li ZH, et al
    Preoperative prediction of positive margins in breast-conserving surgery using an ensemble model based on DCE-MRI: a multi-center retrospective and prospective study.
    Breast Cancer Res. 2026;28:181.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

25. REES S, Bodelon C, Chakraborty S, Millen AE, et al
    Change in alcohol consumption and all-cause mortality among postmenopausal women diagnosed with breast cancer.
    Breast Cancer Res Treat. 2026;220:14.
    

    >> Share

    
    
26. FONT-TORRES O, Khedr S, Ende V, Hong J, et al
    Recent trends in race and ethnicity reporting in breast surgery journals.
    Breast Cancer Res Treat. 2026;220:13.
    

    >> Share

    
    
27. DE BONIFACE J, Szulkin R, Karlsson P, Johansson ALV, et al
    Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.
    Breast Cancer Res Treat. 2026;220:10.
    

    >> Share

    
    
28. LEE SF, Admojo L, Lin YH, Yip PL, et al
    Outcomes of postmastectomy radiotherapy in immediate autologous versus implant-based breast reconstruction: a multi-institutional cohort study.
    Breast Cancer Res Treat. 2026;220:12.
    

    >> Share

    
    
29. MEHRA S, Hong J, Yeh C, Su J, et al
    A breast clinical scoring system to identify women with Idiopathic granulomatous Mastitis.
    Breast Cancer Res Treat. 2026;220:11.
    

    >> Share

    
    
30. FISHMAN MDC, Lamb LR, Haver HL, Giess CS, et al
    Artificial intelligence decision support for breast ultrasound: potential to reduce benign biopsies.
    Breast Cancer Res Treat. 2026;220:8.
    

    >> Share

    
    
31. FATIMA Z, Choudhary S, Choudhary HZ
    Comment on "Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival".
    Breast Cancer Res Treat. 2026;220:9.
    

    >> Share

    
    
32. GONZALES SR, Ramesh U, O'Malley AJ, Brooks GA, et al
    Associations of surgical breast cancer treatment at regional or community hospitals with patient-reported experience measures.
    Breast Cancer Res Treat. 2026;220:4.
    

    >> Share

    
    
33. PARKINSON G, Friedman S, Hodan R, Kurian AW, et al
    Awareness, need and utilization of breast cancer risk management resources in women with hereditary cancer susceptibility.
    Breast Cancer Res Treat. 2026;220:5.
    

    >> Share

    
    
34. BROKAW DS, Kozian L, Chang C, Shulman RM, et al
    National trends in dual de-escalation of axillary surgery and adjuvant radiation in early-stage HR+/HER2- breast cancer.
    Breast Cancer Res Treat. 2026;220:6.
    

    >> Share

    
    
35. YILDIRIM H, Coskunpinar E, Tukenmez M, Mollavelioglu B, et al
    Investigation of DNA methylation levels before and after treatment in breast cancer patients receiving neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2026;220:2.
    

    >> Share

    
    
36. SU M, Klatzkow H, Bass R, Bhat S, et al
    Patterns of social determinants of health screening and health-related social needs among patients with newly diagnosed breast cancer in a safety-net system.
    Breast Cancer Res Treat. 2026;220:1.
    

    >> Share

    
    
37. BRENNAN M, Javid SH, Flanagan MR, Schmicker R, et al
    Surgical management in HER2 + de novo metastatic breast cancer: disease progression and survival.
    Breast Cancer Res Treat. 2026;220:7.
    

    >> Share

    
    
38. ERIKSSON J, Fredriksson I, Lindholm L, Appelblad M, et al
    Diagnosis-to-surgery lead time and future-health worry in women with primary breast cancer: a longitudinal Swedish registry-based cohort study.
    Breast Cancer Res Treat. 2026;220:3.
    

    >> Share

    
    

    
    Breast J

39. MUSHII O, Lukianova Y, Bazas V
    Intratumoral Microbiome-Tumor Microenvironment Crosstalk in Breast Cancer Aggressiveness.
    Breast J. 2026;2026:e1508684.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

40. BUSTER JA, Sharma V, Myers DJ, Johnson CJ, et al
    Examining Rural-Urban Differences in Genomic Testing Use for Breast Cancer in Idaho, 2013-2022.
    Cancer Epidemiol Biomarkers Prev. 2026.
    

    >> Share

    
    

    
    Clin Breast Cancer

41. LINDEN HM, O'Brien SR, van de Ven SM, La Porte P, et al
    Clinical Utility of [(18)F]Fluoroestradiol PET/CT to Guide Second Line Treatment Decision in ER-Positive HER2-Negative Metastatic Breast Cancer After Progression on First Line Endocrine Therapy.
    Clin Breast Cancer. 2026;26:32-39.
    

    >> Share

    
    

    
    Clin Exp Metastasis

42. NIU L, Zhu L, Zhang Q, Bai Y, et al
    Surgical resection versus stereotactic body radiotherapy for oligometastatic breast cancer to the liver.
    Clin Exp Metastasis. 2026;43:55.
    

    >> Share

    
    

    
    CMAJ

43. THOMAS P, Carter B, Earle CC, Shariff SZ, et al
    Factors associated with early death from de novo metastatic breast cancer in Ontario, Canada.
    CMAJ. 2026;198:E1392-E1403.
    

    >> Share

    
    
44. FENG NL, Wilkinson AN, Delpero E, Srikanthan A, et al
    Neurokinin-3 receptor antagonists for vasomotor symptoms in menopause and breast cancer survivorship.
    CMAJ. 2026;198:E1404-E1406.
    

    >> Share

    
    

    
    Eur J Cancer

45. SERRANO D, Lazzeroni M, Rizzo R, Gnagnarella P, et al
    Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
    Eur J Cancer. 2026;248:117784.
    

    >> Share

    
    

    
    Int J Cancer

46. XU H, Wang Y, Sa Q, Zhou Y, et al
    BRCAness-Driven Prognostic Model and Regimen-Specific Therapeutic Implications in Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.
    Int J Cancer. 2026 Oct 17. doi: 10.1002/ijc.70765.
    

    >> Share

    
    
47. PARK B, Yoon J, Trang NTH, Jeon S, et al
    Impact of Childbearing and Breastfeeding on Breast Density Change, and Subsequent Breast Cancer Risk in Postmenopausal Women: A Mediation Analysis.
    Int J Cancer. 2026 Oct 22. doi: 10.1002/ijc.70796.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

48. LIU J, Lin X, Yu J, Bi Z, et al
    Concurrent Versus Sequential Postoperative Radiotherapy and CDK4/6 Inhibitors in Breast Cancer with Positive Regional Nodes: A Multi-Center Safety and Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2026 Oct 22:S0360-3016(26)04385.
    

    >> Share

    
    

    
    J Clin Oncol

49. WANG X, Zhang X, Chen X, Yang Z, et al
    Hypofractionated Versus Conventionally Fractionated Postmastectomy Radiotherapy With Internal Mammary Node Irradiation for High-Risk Breast Cancer (HypoMast-IMNI): A Randomized Phase III Trial.
    J Clin Oncol. 2026 Oct 19:JCO2502843. doi: 10.1200/JCO-25-02843.
    

    >> Share

    
    
50. LI ZQ, Wu SY, Ge LP, Wu XR, et al
    Association of Circulating Eosinophils With Systemic Immune Activation and Reduced Recurrence in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    J Clin Oncol. 2026 Oct 20:JCO2600261. doi: 10.1200/JCO-26-00261.
    

    >> Share

    
    

    
    J Natl Cancer Inst

51. QIN X, Chen J, Trinkoff A, Yee D, et al
    Claims-based frailty, dual eligibility, and potential unmet home-health needs in older breast cancer survivors.
    J Natl Cancer Inst. 2026 Oct 19:djag327. doi: 10.1093.
    

    >> Share

    
    

    
    JAMA

52. ANGUS DC, O'Connor MB, Young LJ
    Breast Cancer's Transformation From Terminal to Manageable: A Healthy Dialogue With Nancy E. Davidson.
    JAMA. 2026 Oct 22:e2621078. doi: 10.1001/jama.2026.21078.
    

    >> Share

    
    

    
    Nat Rev Cancer

53. BREWER G
    Lean, mean, breast cancer-fighting machine.
    Nat Rev Cancer. 2026 Oct 16. doi: 10.1038/s41568-026-00996.
    

    >> Share

    
    

    
    Nature

54. SUN R, Qian L, Li Y, Liu T, et al
    An operational perturbation proteomics-based virtual cell model.
    Nature. 2026;658:1066-1076.
    

    >> Share

    
    

    
    Oncogene

55. CHEN C, Zhang Y, Liu C, Zhao R, et al
    Targeting the PRMT5-CBX8 axis overcomes dual barriers of CD8(+) T cell exclusion and tumor stemness for sensitizing TNBC to anti-PD-1 therapy.
    Oncogene. 2026;45:4659-4672.
    

    >> Share

    
    

    
    Oncology

56. KAI X, Li K
    Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning of MRI Radiomics.
    Oncology. 2026 Oct 22:1. doi: 10.1159.
    

    >> Share

    
    

    
    PLoS One

57. SHI H, Song Z, Chen Y, Liu S, et al
    The global burden of female breast cancer attributable to high fasting plasma glucose: A comprehensive analysis of the GBD database from 1990 to 2023.
    PLoS One. 2026;21:e0359268.
    

    >> Share

    
    

    
    Pol J Radiol

58. SI J, Xu Q, He X, Shi F, et al
    Abbreviated MRI protocol in breast cancer diagnosis: comparison with the full diagnostic protocol.
    Pol J Radiol. 2026;91:e396-e409.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share